Join
Search

Posts Tagged ‘scientific integrity policies’

Measuring Progress on Scientific Integrity Two Years Later

Two years ago today, John Holdren, Assistant to the President for Science and Technology and Director of the Office of Science and Technology Policy, sent a memorandum to government leaders regarding one of the president’s early priorities: creating strong scientific integrity standards within the executive branch in order to prevent political interference in science. Read More

Bookmark and Share

Fish and Wildlife Service Scientists Get Some Clarity on Communicating With the Press

In keeping with its commitment to improving its scientific integrity standards, the U.S. Fish and Wildlife Service has updated its public communication and media policy—for the first time in two decades (to put that in perspective, that’s before the vast majority of us used the Internet). The policy is a marked improvement from the agency’s previous policy and succeeds by clarifying the roles and responsibilities of Service employees and public affairs officials in the communication of scientific information. But despite these improvements, the agency is not out of the woods quite yet. Read More

Bookmark and Share

New Report Details What Should Happen When Scientists at FDA Disagree

Should scientists at the Food and Drug Administration be able to have honest disputes with their colleagues about the science behind a drug or medical device approval decision? Or should they keep quiet about their concerns, preferring not to rock the boat? Read More

Bookmark and Share

Why Must NASA Scientific Integrity Policy be so Daunting and Difficult to Navigate?

In an email yesterday to NASA employees (reproduced below), NASA Chief Scientist Waleed Abdalati reaffirmed the agency’s commitment to scientific integrity, touting the scientific integrity policy NASA finalized in December.  If only the scientists who work there could navigate through it. Read More

Bookmark and Share

As Scientific Integrity Policies Roll In, What Comes Next?

Today is the deadline for federal agencies and departments to publicly announce final or “final draft” policies designed to prevent political and corporate interference in the science behind government decision-making. The results, as expected, are all over the board. We’re keeping track here. Read More

Bookmark and Share

How the FDA Drug Approval Process Works

Earlier this week, my colleague Michael gave some general background on the Food and Drug Administration and what Congress has to do this year to ensure that the agency can continue to ensure the safety and efficacy of prescription drugs and medical devices. Read More

Bookmark and Share

Survey: Despite Progress, FDA Scientists Feel Political and Industry Pressure

UCS released a survey of 997 FDA scientists this morning which found that while FDA leaders are working hard to boost scientific integrity at the agency, persistent interference by special interests continues to hinder scientists’ work.  The FDA responded quickly and reasonably, stressing its successes while acknowledging that improvements can and should be made. National Public Radio science reporter Nell Greenfieldboyce was first out of the gate with a quick summary of the findings and FDA’s response. Read More

Bookmark and Share

The EPA Follows Through on Dioxin

February brought two significant pieces of good news at the EPA. The agency released its final scientific integrity policy, which was much improved over the draft it put out for public comment. And the EPA finally released a scientific assessment of dioxin, an achievement 27 years in the making. Read More

Bookmark and Share

Final EPA Scientific Integrity Policy Benefited Greatly from Public Input — and Now the Really Hard Work Begins

Under Administrator Lisa Jackson’s tenure, the EPA has worked to restore public trust in the agency. On her first day, she issued a “fishbowl” memo that committed the agency to three core values: scientific integrity, transparency, and the rule of law. This week, the EPA released its long-awaited scientific integrity policy and, as with other agencies, there is significant improvement over the first draft. Read More

Bookmark and Share

Science Advocates Tell PCAST to Engage on Scientific Integrity

Today, along with four others, I testified before the President’s Council of Advisors on Science and Technology, popularly known as PCAST. The topic: the administration’s failure to follow the law and allow over-the-counter access to Plan B emergency contraception. Read More

Bookmark and Share